title: A new basophil activation test using CD63 and CCR3 in allergy to antibiotics.
abstract: BACKGROUND
  Flow cytometric basophil activation tests (BAT) have been developed as cellular tests for in vitro diagnosis of IgE-mediated reactions. Different markers and techniques have been used after stimulation with various allergens.
  
  
  OBJECTIVE
  It was the aim of the present study to compare an established BAT (Flow-CAST) with a newly developed basophil activation protocol using CD63 and CCR3 (Flow2 CAST) in patients with type-I allergy to antibiotics.
  
  
  METHODS
  Twenty-four patients with a history of type-I allergy to antibiotics were examined. A careful allergy history was taken, and skin tests and determination of specific IgE antibodies were performed. Two different BAT using CD63 expression but different protocols were carried out after stimulation with different concentrations of antibiotics. Fifteen healthy subjects without a history of antibiotic allergy were studied as controls.
  
  
  RESULTS
  The Flow2 CAST showed a higher sensitivity than the Flow-CAST (55% vs. 53%) with regard to patients' history. Specificity was 80% both for the Flow2 CAST and for the Flow-CAST with regard to controls with negative history and negative RAST.
  
  
  CONCLUSIONS
  These results show the value of two different BAT as cellular tests in the in vitro diagnosis of patients with antibiotic allergy with equal specificity and a slightly higher sensitivity for the Flow2 CAST.
authors.affiliation: Helmholtz Center Munich for Environmental Health/TUM, Division of Environmental Dermatology and Allergology, Munich, Germany. eberlein@lrz.tum.de
authors.forename: B
authors.initials: B
authors.lastname: Eberlein
authors.forename: I
authors.initials: I
authors.lastname: León Suárez
authors.forename: U
authors.initials: U
authors.lastname: Darsow
authors.forename: F
authors.initials: F
authors.lastname: Ruëff
authors.forename: H
authors.initials: H
authors.lastname: Behrendt
authors.forename: J
authors.initials: J
authors.lastname: Ring
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000276:immunology*; D000937:Antigen-Antibody Reactions; D015703:Antigens, CD / Q000276:immunology*; D015549:Basophil Degranulation Test; D002648:Child; D002675:Child, Preschool; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D007223:Infant; D008297:Male; D010980:Platelet Membrane Glycoproteins / Q000276:immunology*; D054397:Receptors, CCR3 / Q000276:immunology*; D012680:Sensitivity and Specificity; D012882:Skin Tests; D060149:Tetraspanin 30
chemical_list: D000900:Anti-Bacterial Agents; D015703:Antigens, CD; C515350:CCR3 protein, human; C554586:CD63 protein, human; D010980:Platelet Membrane Glycoproteins; D054397:Receptors, CCR3; D060149:Tetraspanin 30; D007073:Immunoglobulin E